Laboratoire de Bactériologie-Hygiène, et UMR9, Faculté de Médecine Pierre et Marie Curie, Site Pitié-Salpêtrière, Paris, France.
J Clin Microbiol. 2011 Mar;49(3):1048-57. doi: 10.1128/JCM.02130-10. Epub 2011 Jan 19.
The detection of extended-spectrum β-lactamase-producing (ESBL) bacteria is of importance for infection control and epidemiological surveillance. We aimed to compare phenotypic methods available in the routine laboratory and to evaluate two-step strategies using these methods for the detection of ESBL-positive Enterobacteriaceae. Two methods used for routine susceptibility testing (Vitek2 and disk diffusion methods) and seven methods designed for the detection of ESBL production (ESBL Etests, combination disks, double-disk synergy [DDS] methods on Mueller-Hinton [MH] agar and cloxacillin-containing MH agar, and the Cica-Beta test) were tested against 107 strains of Enterobacteriaceae not susceptible to extended-spectrum cephalosporins. All strains were screened for the presence of acquired ESBL-encoding genes by PCR, and the PCR result was considered the gold standard for evaluation of the other test methods. Among the 107 strains, 52 (49%) were ESBL positive. With Vitek2, sensitivities were the highest when using extended cards (73% to 79%), but 25% to 31% of the strains yielded indeterminate results. For the disk diffusion method, sensitivities were the highest (96%) when testing at least cefotaxime, cefepime, and a third compound (ceftazidime, cefpodoxime, or aztreonam). For the specific methods, specificities ranged from 62% (ceftazidime ESBL Etest) to 100% (DDS using a disk spacing of 20 mm). When a method designed for ESBL detection was used on strains considered ESBL negative or with an indeterminate result by a first routine susceptibility method, sensitivities reached 100% for a majority of combinations. In conclusion, two-step strategies using phenotypic methods available in most clinical laboratories may reach a sensitivity of 100% for ESBL detection among a large panel of species, including AmpC producers, providing a sensible choice of tests.
检测产超广谱β-内酰胺酶(ESBL)的细菌对于感染控制和流行病学监测非常重要。我们旨在比较常规实验室中可用的表型方法,并评估使用这些方法的两步策略用于检测产 ESBL 的肠杆菌科。两种用于常规药敏试验的方法(Vitek2 和纸片扩散法)和七种用于检测 ESBL 产生的方法(ESBL Etests、组合纸片、MH 琼脂上的双纸片协同法和含氯唑西林的 MH 琼脂上的双纸片协同法,以及 Cica-Beta 试验)用于检测对扩展头孢菌素不敏感的 107 株肠杆菌科细菌。所有菌株均通过 PCR 筛选是否存在获得性 ESBL 编码基因,PCR 结果被认为是评估其他测试方法的金标准。在 107 株菌株中,52 株(49%)为 ESBL 阳性。使用 Vitek2,使用扩展卡时灵敏度最高(73%至 79%),但 25%至 31%的菌株产生不确定结果。对于纸片扩散法,至少测试头孢噻肟、头孢吡肟和第三种化合物(头孢他啶、头孢泊肟或氨曲南)时灵敏度最高(96%)。对于特定方法,特异性范围从 62%(头孢他啶 ESBL Etest)到 100%(DDS 使用 20 毫米间距的纸片)。当在被认为是 ESBL 阴性的菌株或使用第一种常规药敏方法产生不确定结果的菌株上使用设计用于 ESBL 检测的方法时,大多数组合的灵敏度达到 100%。总之,使用大多数临床实验室中可用的表型方法的两步策略可在包括 AmpC 产生菌在内的大量物种中达到 100%的 ESBL 检测灵敏度,为测试提供了合理的选择。